A significant global public health concern, dementia now affects 50 million individuals and is projected to reach more than 150 million cases by 2050. An ongoing global problem is obesity, which is typically assessed by body mass index (BMI). Previous research has revealed that obesity in mi
Union Minister of Health and Family Welfare Mansukh Mandaviya on Sunday addressed the 6th Meeting of the Central Institute Body (CIB), the highest decision-making body of all AIIMS, to review compliance of decisions taken in earlier CIB meetings in Odisha's Bhubaneswar.
A new USC Leonard Davis School of Gerontology study challenges existing ideas of how the buildup of a protein called amyloid beta (Ab) in the brain is related to Alzheimer's disease.
Scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported that an inflammatory trigger like one present during viral infections is elevated in Alzheimer's disease and progressive supranuclear palsy, a rare brain disorder.
Police submitted the charge sheet before the First Class Judicial Magistrate Court at Ernakulam regarding the murder of Padma, who was a Tamil Nadu native, officials said.
The Haryana Police booked a First Information Report (FIR) against a man, who in an inebriated state allegedly attacked a woman with his helmet after she refused to sit with him on his bike. The National Commission for Women (NCW) on Saturday took cognisance of the incident seeking a time-bo
In a new study, U.S. and Danish researchers report that patients hospitalized with Lyme disease had a 28 per cent higher rate of mental disorders and were twice as likely to have attempted suicide post-infection, compared to individuals without the diagnosis.
Following a heart attack, the human body is incapable of repairing lost tissue due to the heart's inability to generate new muscle. However, treatment with heart progenitor cells could result in the formation of functional heart cells at injured sites. This new therapeutic approach is introd
A potentially game-changing treatment for people with, or at risk of, blood clots have been found effective by an international team of researchers led by McMaster University's Jeffrey Weitz.
Lipopolysaccharide, a virulence factor produced by bacteria, is a toxin that can cause systemic inflammation via circulation. In a recently completed study, genetic markers were discovered that are associated with a heightened lipopolysaccharide level in the blood.